208 related articles for article (PubMed ID: 19752552)
1. Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke.
Bal Dit Sollier C; Crassard I; Simoneau G; Bergmann JF; Bousser MG; Drouet L
Cerebrovasc Dis; 2009; 28(5):505-13. PubMed ID: 19752552
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
3. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
[TBL] [Abstract][Full Text] [Related]
4. Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.
Gelosa P; Ballerio R; Banfi C; Nobili E; Gianella A; Pignieri A; Brioschi M; Guerrini U; Castiglioni L; Blanc-Guillemaud V; Lerond L; Tremoli E; Sironi L
J Pharmacol Exp Ther; 2010 Jul; 334(1):199-205. PubMed ID: 20332187
[TBL] [Abstract][Full Text] [Related]
5. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
Hennerici MG;
Cerebrovasc Dis; 2009; 27 Suppl 3():28-32. PubMed ID: 19439938
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
8. TP receptor antagonism: a new concept in atherothrombosis and stroke prevention.
Chamorro A
Cerebrovasc Dis; 2009; 27 Suppl 3():20-7. PubMed ID: 19439937
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
[TBL] [Abstract][Full Text] [Related]
10. Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients.
Serebruany VL; Malinin AI; Atar D
Cardiology; 2007; 107(4):307-12. PubMed ID: 17264511
[TBL] [Abstract][Full Text] [Related]
11. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH
Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
13. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
Pongrácz E
Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
[TBL] [Abstract][Full Text] [Related]
14. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD;
Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527
[TBL] [Abstract][Full Text] [Related]
15. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
16. [Terutroban and endothelial TP receptors in atherogenesis].
Verbeuren TJ
Med Sci (Paris); 2006 Apr; 22(4):437-43. PubMed ID: 16597416
[TBL] [Abstract][Full Text] [Related]
17. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.
Bhatt DL; Kapadia SR; Bajzer CT; Chew DP; Ziada KM; Mukherjee D; Roffi M; Topol EJ; Yadav JS
J Invasive Cardiol; 2001 Dec; 13(12):767-71. PubMed ID: 11731685
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
[TBL] [Abstract][Full Text] [Related]
19. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
[TBL] [Abstract][Full Text] [Related]
20. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
